Prevention of Ischaemic Stroke

Overview

Journal BMJ

Specialty General Medicine

Date 2000 Dec 9

PMID 11110741

Citations 6

Authors

G Gubitz

P Sandercock

Affiliations

Soon will be listed here.

Citing Articles

Use of antithrombotic medications among elderly ischemic stroke patients.

Lichtman J, Naert L, Allen N, Watanabe E, Jones S, Barry L Circ Cardiovasc Qual Outcomes. 2010; 4(1):30-8.

PMID: 21098780 PMC: 3073519. DOI: 10.1161/CIRCOUTCOMES.109.850883.

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services.

Coull A, Lovett J, Rothwell P BMJ. 2004; 328(7435):326.

PMID: 14744823 PMC: 338101. DOI: 10.1136/bmj.37991.635266.44.

Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack.

Clark T, Murphy M, Rothwell P J Neurol Neurosurg Psychiatry. 2003; 74(5):577-80.

PMID: 12700296 PMC: 1738460. DOI: 10.1136/jnnp.74.5.577.

Suicide in a patient with symptomatic carotid occlusion.

Lovett J, Rothwell P J R Soc Med. 2002; 95(2):93-4.

PMID: 11823555 PMC: 1279321. DOI: 10.1177/014107680209500212.

Arterial indications for the low molecular weight heparins.

Ageno W, Huisman M Curr Control Trials Cardiovasc Med. 2002; 2(5):233-239.

PMID: 11806802 PMC: 59526. DOI: 10.1186/cvm-2-5-233.

References

. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. Am J Cardiol. 1995; 75(16):1130-4. DOI: 10.1016/s0002-9149(99)80744-9. View

Wannamethee S, Shaper A . Physical activity and the prevention of stroke. J Cardiovasc Risk. 1999; 6(4):213-6. DOI: 10.1177/204748739900600404. View

Chen Z, Sandercock P, Pan H, Counsell C, Collins R, Liu L . Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000; 31(6):1240-9. DOI: 10.1161/01.str.31.6.1240. View

Peto R . Smoking and death: the past 40 years and the next 40. BMJ. 1994; 309(6959):937-9. PMC: 2541135. DOI: 10.1136/bmj.309.6959.937. View

. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration. BMJ. 1997; 314(7088):1151-9. PMC: 2126525. View

Hebert P, Gaziano J, Chan K, Hennekens C . Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA. 1997; 278(4):313-21. View

Gorelick P, Sacco R, Smith D, Alberts M, Rader D, Ross J . Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999; 281(12):1112-20. DOI: 10.1001/jama.281.12.1112. View

Alberts M . tPA in acute ischemic stroke: United States experience and issues for the future. Neurology. 1998; 51(3 Suppl 3):S53-5. DOI: 10.1212/wnl.51.3_suppl_3.s53. View

Hansson L, Lindholm L, Ekbom T, Dahlof B, Lanke J, SCHERSTEN B . Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet. 1999; 354(9192):1751-6. DOI: 10.1016/s0140-6736(99)10327-1. View

10.

Benavente O, Moher D, Pham B . Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ. 1998; 317(7171):1477-80. PMC: 28726. DOI: 10.1136/bmj.317.7171.1477. View

11.

Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M . Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. Stroke. 1997; 28(5):1015-21. DOI: 10.1161/01.str.28.5.1015. View

12.

Pekkanen J, Linn S, Heiss G, Suchindran C, Leon A, Rifkind B . Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med. 1990; 322(24):1700-7. DOI: 10.1056/NEJM199006143222403. View

13.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000; 342(3):145-53. DOI: 10.1056/NEJM200001203420301. View

14.

. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS. J Hypertens Suppl. 1996; 14(2):S41-5; discussion S45-6. View

15.

Taylor D, Barnett H, Haynes R, Ferguson G, Sackett D, Thorpe K . Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet. 1999; 353(9171):2179-84. DOI: 10.1016/s0140-6736(99)05388-x. View

16.

Hankey G, Warlow C . Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet. 1999; 354(9188):1457-63. DOI: 10.1016/S0140-6736(99)04407-4. View

17.

Gubitz G, Sandercock P, Counsell C . Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2000; (2):CD000029. DOI: 10.1002/14651858.CD000029. View

18.

Murray C, Lopez A . Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349(9061):1269-76. DOI: 10.1016/S0140-6736(96)07493-4. View

19.

Hankey G, Sudlow C, Dunbabin D . Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev. 2000; (2):CD001246. DOI: 10.1002/14651858.CD001246. View

20.

Diener H, Cunha L, Forbes C, Sivenius J, Smets P, LOWENTHAL A . European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996; 143(1-2):1-13. DOI: 10.1016/s0022-510x(96)00308-5. View